Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate for Nonoccupational HIV-1 Postexposure Prophylaxis: A Prospective Open-Label Trial (DORAVIPEP).

Alexy InciarteAinoa UgarteMaría Martínez-RebollarBerta TorresEmma FernándezLeire BerrocalMontserrat LagunoLorena De la MoraElisa De LazzariPilar CallauIván ChiviteAna González-CordónEstela SolbesVerónica RicoLaura BarreroJosé Luis BlancoEsteban MartínezJuan AmbrosioniJosep Mallolasnull null

Published in: Open forum infectious diseases (2023)

NCT04233372.

Keyphrases

antiretroviral therapy
open label
hiv infected patients
phase iii
phase ii
hiv infected
study protocol
hiv positive
human immunodeficiency virus
clinical trial
hiv aids
hiv testing
phase ii study
hepatitis c virus
randomized controlled trial
men who have sex with men
double blind
rectal cancer